[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 780
Citations 0
Correction
April 22, 2020

Errors in Conflict of Interest Disclosures

JAMA Psychiatry. 2020;77(7):768. doi:10.1001/jamapsychiatry.2020.0724

In the Original Investigation titled “Efficacy of Digital Cognitive Behavioral Therapy for the Treatment of Insomnia Symptoms Among Pregnant Women: A Randomized Clinical Trial,”1 published online on January 22, 2020, there was an error in the Conflict of Interest Disclosures section. The Conflict of Interest Disclosures have been updated to add grants from Axsome Therapeutics and Reveal Biosensors and personal fees from Adare, Millennium Pharmaceuticals, Pernix, and Otsuka Pharmaceutical for Dr Krystal. Dr Krystal has written a Letter2 explaining the omission. This article was corrected online.

References
1.
Felder  JN, Epel  ES, Neuhaus  J, Krystal  AD, Prather  AA.  Efficacy of digital cognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a randomized clinical trial.   JAMA Psychiatry. Published online January 22, 2020. doi:10.1001/jamapsychiatry.2019.4491PubMedGoogle Scholar
2.
Krystal  AD.  Omitted conflict of interest disclosures.   JAMA Psychiatry. Published online April 22, 2020. doi:10.1001/jamapsychiatry.2020.0616PubMedGoogle Scholar
×